ReviewDer Orthopade2019
Primary clear cell sarcoma of the calcaneus : Report of a rare case and review of the literature.
Review in Der Orthopade, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- Primary clear cell sarcoma of the femur: a unique case with RT-PCR and direct sequencing confirmation of EWSR1/ATF1 fusion gene.BMC musculoskeletal disorders · 2021Article
- Is Magnetic Resonance Imaging Able to Provide Specific Diagnoses? A Case Report of Clear Cell Sarcoma of Soft Tissue in the First Metacarpal of the Hand.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clear cell sarcoma (CCS) is a rare soft tissue tumor derived from neural crest cells. It accounts for 1% of all soft tissue sarcomas and usually involves the tendons and aponeuroses in the distal ends of the extremities. The foot and the ankle are the most common primary sites. A CCS predominantly occurs in young adults and has rarely been reported in children and older people. On magnetic resonance imaging the tumor has a benign appearance. It appears isointense, hypointense or slightly hyperintense on T1-weighted images. A CCS is typically strongly positive for HMB-45, S‑100, melanA, MITF and vimentin on immunohistochemical investigations and exhibits the t(12;22)(q13;q12) translocation on cytogenetic studies. Metastasis occurs mainly to the regional lymph nodes. A tumor size ≥5 cm is invariably associated with a poor prognosis. The main treatment is wide excision but local recurrence and distant metastases are common. This article presents the case of a 61-year-old man with right ankle tenderness and malaise. Ultrasound-guided biopsy and pathological examination were performed and the pathological diagnosis was a CCS. The patient underwent a below-knee amputation and had no local recurrence or metastasis at the 6‑month follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.